Effects of concomitant inactivation of p53 and pRb on response to doxorubicin treatment in breast cancer cell lines
Crossref DOI link: https://doi.org/10.1038/cddiscovery.2017.26
Published Online: 2017-05-22
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Huun, Johanna
Lønning, Per Eystein
Knappskog, Stian
Text and Data Mining valid from 2017-05-22
Version of Record valid from 2017-05-22
Article History
Received: 30 November 2016
Revised: 27 February 2017
Accepted: 4 April 2017
First Online: 22 May 2017
Competing interests
: The authors declare no conflict of interest.